Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Celecoxib for the prevention of sporadic colorectal adenomas.
Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET; APC Study Investigators. Bertagnolli MM, et al. Among authors: hawk et. N Engl J Med. 2006 Aug 31;355(9):873-84. doi: 10.1056/NEJMoa061355. N Engl J Med. 2006. PMID: 16943400 Free article. Clinical Trial.
Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM. Cho NL, et al. Among authors: hawk et. Cancer Prev Res (Phila). 2008 Jun;1(1):21-31. doi: 10.1158/1940-6207.CAPR-07-0011. Epub 2008 Apr 14. Cancer Prev Res (Phila). 2008. PMID: 19138933 Clinical Trial.
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.
Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET; Adenoma Prevention with Celecoxib Study Investigators. Bertagnolli MM, et al. Among authors: hawk et. Cancer Prev Res (Phila). 2009 Apr;2(4):310-21. doi: 10.1158/1940-6207.CAPR-08-0206. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336730 Free PMC article. Clinical Trial.
The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo.
Arber N, Lieberman D, Wang TC, Zhang R, Sands GH, Bertagnolli MM, Hawk ET, Eagle C, Coindreau J, Zauber A, Lanas A, Levin B. Arber N, et al. Among authors: hawk et. Clin Ther. 2012 Mar;34(3):569-79. doi: 10.1016/j.clinthera.2012.02.001. Epub 2012 Mar 2. Clin Ther. 2012. PMID: 22386831 Clinical Trial.
Urinary PGE-M in colorectal cancer: predicting more than risk?
Colbert Maresso K, Vilar E, Hawk ET. Colbert Maresso K, et al. Among authors: hawk et. Cancer Prev Res (Phila). 2014 Oct;7(10):969-72. doi: 10.1158/1940-6207.CAPR-14-0215. Epub 2014 Jul 28. Cancer Prev Res (Phila). 2014. PMID: 25070664 Free PMC article.
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC; Familial Adenomatous Polyposis Study Group. Sinicrope FA, et al. Among authors: hawk et. Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):920-7. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15184247 Clinical Trial.
159 results